Carl Zeiss Meditec AGXSWX:AFX 79 Interest Coverage is 0.14 as of Dec. 2025, which is 100% below its 10-year median of 36.07. GuruFocus rates XSWX:AFX with a GF Score™ of 79/100 and a GF Value™ of CHF67.74 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 468 Medical Devices & Instruments companies, Carl Zeiss Meditec AG ranks worse than 67.09% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Carl Zeiss Meditec AG's
Operating Income
for the
three
months ended in Dec. 2025 was CHF1 Mil. Carl Zeiss Meditec AG's Interest Expense for the
three
months ended in Dec. 2025 was CHF-7 Mil.
Carl Zeiss Meditec AG's interest coverage for the quarter that ended in Dec. 2025 was 0.14.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Carl Zeiss Meditec AG's Interest Coverage or its related term are showing as below:
XSWX:AFX'
s Interest Coverage Range Over the Past 10 Years
Min: 6.37 Med: 36.07 Max: 74.19
Current: 7.23
XSWX:AFX's Interest Coverage is ranked worse than 67.09% of 468
companies
in the Medical Devices & Instruments industry
Industry Median: 15.71
vs XSWX:AFX: 7.23
Carl Zeiss Meditec AG (XSWX:AFX) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Carl Zeiss Meditec AG Interest Coverage Related Terms
Carl Zeiss Meditec AG Interest Coverage Historical Data
* Premium members only.
The historical data trend for Carl Zeiss Meditec AG's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
XSWX:AFX vs ISRG, BDX, MDLN: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carl Zeiss Meditec AG Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Carl Zeiss Meditec AG's Interest Coverage falls into.
Carl Zeiss Meditec AG Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carl Zeiss Meditec AG (XSWX:AFX) has a Interest Coverage of 0.14 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Carl Zeiss Meditec AG and its competitors. This is 100% below median its historical median of 36.07. Over the past decade, Carl Zeiss Meditec AG's Interest Coverage has ranged from 6.37 to 74.19. According to the industry distribution chart, Carl Zeiss Meditec AG ranks #314 out of 468 companies in the Medical Devices & Instruments industry, placing it in the top 67.1%.
Is Carl Zeiss Meditec AG's Interest Coverage too high?
Carl Zeiss Meditec AG's current Interest Coverage of 0.14 is 100% below median its 10-year median of 36.07. Over the past 10 years, this metric has ranged from a low of 6.37 to a high of 74.19. The Medical Devices & Instruments industry median Interest Coverage is 15.71. Carl Zeiss Meditec AG's value of 0.14 is 99.1% below this industry median. Based on the distribution chart, Carl Zeiss Meditec AG ranks #314 out of 468 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Carl Zeiss Meditec AG has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Carl Zeiss Meditec AG's Interest Coverage compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Carl Zeiss Meditec AG ranks #314 out of 468 companies for Interest Coverage. This places Carl Zeiss Meditec AG in the lower half of its industry. The industry median Interest Coverage is 15.71. Carl Zeiss Meditec AG's value of 0.14 is 99.1% below this benchmark. Historically, Carl Zeiss Meditec AG's own Interest Coverage has ranged from 6.37 to 74.19 over the past decade. While the company's 10-year median is 36.07 vs. the industry median of 15.71, Carl Zeiss Meditec AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.71, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Carl Zeiss Meditec AG's current Interest Coverage of 0.14 is 99.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Carl Zeiss Meditec AG and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carl Zeiss Meditec AG's current Interest Coverage is 0.14, which is 100% below median its own 10-year median of 36.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carl Zeiss Meditec AG stock overvalued right now?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG (XSWX:AFX) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF67.74, compared to a current price of CHF24.80 — trading 63.4% below its estimated fair value. The current Interest Coverage is 0.14, which is 100% below median its 10-year median of 36.07 and 99.1% below the Medical Devices & Instruments industry median of 15.71. Carl Zeiss Meditec AG's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Carl Zeiss Meditec AG (XSWX:AFX), the current Interest Coverage is 0.14 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carl Zeiss Meditec AG (XSWX:AFX) Overvalued in 2026?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued.
The current stock price of CHF24.80 is trading 63.4% below its estimated GF Value™ of CHF67.74.
GuruFocus considers Carl Zeiss Meditec AG to be Significantly Undervalued.
Key valuation signals for XSWX:AFX:
Interest Coverage: 0.14 (100% below median its 10-year median of 36.07)
GF Value™: CHF67.74 vs. price of CHF24.80 (63.4% below fair value)
Industry Position: 99.1% below the Medical Devices & Instruments median (#314 of 468)
No single metric tells the full story. See the XSWX:AFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
79GF Score
Get the complete analysis for XSWX:AFX
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:AFX has been successfully added to your 
